LeMaitre Vascular
LMAT
227 hedge funds and large institutions have $1.16B invested in LeMaitre Vascular in 2023 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 95 increasing their positions, 67 reducing their positions, and 23 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 67
30% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 23
9% more capital invested
Capital invested by funds: $1.06B → $1.16B (+$95.6M)
4.04% more ownership
Funds ownership: 87.51% → 91.55% (+4%)
3% more funds holding
Funds holding: 220 → 227 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less call options, than puts
Call options by funds: $874K | Put options by funds: $1.17M
Top Buyers
Top Sellers
| 1 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$2.32M |
| 2 |
JP Morgan Chase
New York
|
-$2.27M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.1M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.05M |
| 5 |
Goldman Sachs
New York
|
-$1.9M |
LMAT Hedge Fund Activity: Q4 2023 in Review
227 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2023, worth a combined $1.16B — up 9% from $1.06B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new LMAT positions and 23 closed out — a net gain of 7 holders — while 95 added to existing stakes and 67 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $17.6M. The largest seller was State of New Jersey Common Pension Fund D, exiting entirely with an estimated $2.32M sold.
- 227 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2023, up from 220 in Q3 2023.
- Funds reported $1.16B of LeMaitre Vascular stock for Q4 2023, up 9% quarter-over-quarter.
- 30 funds opened new LeMaitre Vascular positions in Q4 2023 and 23 closed out, a net change of +7 holders.
- The largest LeMaitre Vascular buyer in Q4 2023 was Morgan Stanley, an estimated $17.6M added.
- The largest LeMaitre Vascular seller in Q4 2023 was State of New Jersey Common Pension Fund D, an estimated $2.32M sold.
Based on aggregated 13F filings for Q4 2023.